Transforming Liver Care in Thailand:

Point-of-Care Solutions for the MASLD-HBV Dual Burden

Join us for a special academic session featuring Prof. Wai-Kay Seto from The University of Hong Kong, a leading expert in hepatology and liver disease research. As Thailand faces the growing challenge of Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) alongside chronic hepatitis B (HBV), there is an increasing need for accessible, accurate, and non-invasive tools for liver assessment and patient management.



This session will explore the evolving role of point-of-care liver assessment, including AI-enhanced technologies, elastography, and emerging approaches to non-invasive liver evaluation. Participants will gain insights into how these innovations may support clinical decision-making and improve access to liver care in routine practice.



Session Highlights

• MASLD-HBV: Thailand’s Emerging Challenge

• AI-Enhanced Liver Assessment

• Point-of-Care Elastography in Clinical Practice

• Advances in Non-Invasive Liver Assessment

• Future Directions in Hepatology Practice

Speaker

Prof. Wai-Kay Seto The University of Hong Kong

Moderator

Prof. Teerha Piratvisuth, M.D. Songklanagarind Hospital

Date & Time

12 June 2026 14:40 – 15:10 hrs.

Venue

Hotel Nikko Bangkok Sukhumvit 55, Bangkok

Organized by



ZEST-MED Co., Ltd.

Meet Prof. Wai-Kay Seto

HKU Excellence Awardee and leading expert in chronic hepatitis B and liver disease research.